Literature DB >> 32407467

Clinical Features and Outcomes of Patients With Human Immunodeficiency Virus With COVID-19.

Cristina Gervasoni1,2, Paola Meraviglia1, Agostino Riva1, Andrea Giacomelli1, Letizia Oreni1, Davide Minisci1, Chiara Atzori1, Annalisa Ridolfo1, Dario Cattaneo2,3.   

Abstract

Little is known about the clinical outcomes of patients with human immunodeficiency virus infected with SARS-CoV-2. We describe 47 patients referred to our hospital between 21 February and 16 April 2020 with proven/probable COVID-19, 45 (96%) of whom fully recovered and 2 who died.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; HIV; SARS-CoV-2; observational study; real-life

Mesh：

Substances：

Year:  2020        PMID： 32407467      PMCID： PMC7239244          DOI： 10.1093/cid/ciaa579

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  79 in total

1.  COVID-19 in Immunocompromised Hosts: What We Know So Far.

Authors:  Monica Fung; Jennifer M Babik
Journal:  Clin Infect Dis       Date:  2020-06-27       Impact factor: 9.079

Review 2.  The interplay between HIV and COVID-19: summary of the data and responses to date.

Authors:  Lillian B Brown; Matthew A Spinelli; Monica Gandhi
Journal:  Curr Opin HIV AIDS       Date:  2021-01       Impact factor: 4.283

3.  Human Immunodeficiency Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Coinfection: A Systematic Review of the Literature and Challenges.

Authors:  Raj H Patel; Arpan Acharya; Hitendra S Chand; Mahesh Mohan; Siddappa N Byrareddy
Journal:  AIDS Res Hum Retroviruses       Date:  2021-03-23       Impact factor: 2.205

4.  Resilience, Anxiety, Stress, and Substance Use Patterns During COVID-19 Pandemic in the Miami Adult Studies on HIV (MASH) Cohort.

Authors:  Janet Diaz-Martinez; Javier A Tamargo; Ivan Delgado-Enciso; Qingyun Liu; Leonardo Acuña; Eduardo Laverde; Manuel A Barbieri; Mary Jo Trepka; Adriana Campa; Suzanne Siminski; Pamina M Gorbach; Marianna K Baum
Journal:  AIDS Behav       Date:  2021-05-19

5.  Comparison of outcomes in HIV-positive and HIV-negative patients with COVID-19.

Authors:  Jacqui Venturas; Jarrod Zamparini; Erica Shaddock; Sarah Stacey; Lyle Murray; Guy A Richards; Ismail Kalla; Adam Mahomed; Farzahna Mohamed; Mervyn Mer; Innocent Maposa; Charles Feldman
Journal:  J Infect       Date:  2021-05-26       Impact factor: 38.637

Review 6.  HIV and COVID-19: Lessons From HIV and STI Harm Reduction Strategies.

Authors:  Ronnie M Gravett; Jeanne M Marrazzo
Journal:  Curr HIV/AIDS Rep       Date:  2021-06-08       Impact factor: 5.071

Review 7.  Tenofovir, Another Inexpensive, Well-Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection.

Authors:  Isabella Zanella; Daniela Zizioli; Francesco Castelli; Eugenia Quiros-Roldan
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-11

Review 8.  A Pandemic within Other Pandemics. When a Multiple Infection of a Host Occurs: SARS-CoV-2, HIV and Mycobacterium tuberculosis.

Authors:  Carmen María González-Domenech; Isabel Pérez-Hernández; Cristina Gómez-Ayerbe; Isabel Viciana Ramos; Rosario Palacios-Muñoz; Jesús Santos
Journal:  Viruses       Date:  2021-05-17       Impact factor: 5.048

9.  Psychometric Properties of a Vaccine Hesitancy Scale Adapted for COVID-19 Vaccination Among People with HIV.

Authors:  Violeta J Rodriguez; Maria L Alcaide; Ana S Salazar; Emily K Montgomerie; Marissa J Maddalon; Deborah L Jones
Journal:  AIDS Behav       Date:  2021-06-17

10.  The Impact of COVID-19 on HIV Self-Management, Affective Symptoms, and Stress in People Living with HIV in the United States.

Authors:  Rachel K Wion; Wendy R Miller
Journal:  AIDS Behav       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.